Simple Summary Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors,
presenting in often challenging clinical scenarios, and require multidisciplinary discussion …

Neuroendocrine neoplasms (NEN) are rare and heterogeneous tumors, originating mostly
from the gastro-entero-pancreatic (GEP) tract followed by the lungs. Multidisciplinary …

Simple Summary Neuroendocrine neoplasms (NENs) are a rare and diverse group of
malignancies which are rising in incidence. Several treatments have been devised for …

ABSTRACT Introduction Peptide Receptor Radionuclide Therapy (PRRT) is a type of
molecular-targeted endo-radionuclide therapy in which unsealed radiolabelled somatostatin …

Opinion statement Neuroendocrine neoplasms (NEN) are a heterogeneous group of
tumours derived from cells of neuroendocrine origin and can potentially arise everywhere in …

Neuroendocrine tumors (NETs) are rare neoplasms characterized by overexpression of
somatostatin receptors (SSTRs). Functional imaging plays a crucial role in management of …

Somatostatin receptor positron emission tomography/computed tomography using 68 Ga-
labeled somatostatin analogs is the mainstay for the evaluation of receptor status in …

Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of tumors, mainly
localized in the gastrointestinal system. What characterizes NENs is the expression of …

Peptide receptor radionuclide therapy (PRRT) has been shown to be an effective treatment
for neuroendocrine tumors (NETs) if curative surgery is not an option. A majority of NETs …

Abstract Purpose & Methods Neuroendocrine neoplasms are a heterogenous group of
tumours, for which nuclear medicine plays an important role in the diagnostic work-up as …